electroCore,

electroCore, EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of electroCore, (ECOR) as of Oct 17, 2026 is -6.13. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -6.42 — a change of -4.43% (higher).

EV/OCF

-6.13

YoY

-4.43%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of electroCore, is 2025 -6.13 . EV/OCF (Enterprise Value to Operating Cash Flow) of electroCore, was 2024 -6.42 . It decreases by -4.43% higher compared to the previous year.

The electroCore, EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
0.34 USD
Jan 1, 2019
-0.67 USD
Jan 1, 2020
-1.63 USD
Jan 1, 2021
-1.36 USD
Jan 1, 2022
-2.13 USD
Jan 1, 2023
-2.91 USD
Jan 1, 2024
-6.42 USD
Jan 1, 2025
-6.13 USD
The electroCore, EV/OCF history
YEAREV/OCFYoY
-6.13-4.43%
-6.42+120.36%
-2.91+36.90%
-2.13+56.78%
-1.36-16.60%
-1.63+141.35%
-0.67-296.59%
0.34-156.98%
-0.60-86.59%
-4.49—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

EV/OCF (Enterprise Value to Operating Cash Flow) of electroCore, is -6.13 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of electroCore, changed from -6.42 to -6.13, representing a -4.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) electroCore, since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s electroCore, with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — electroCore,

All Key Metrics — electroCore,